trial · primary record
Modified Vaccinia Virus Ankara Vaccine Expressing p53
Recurrent Platinum-Resistant Fallopian Tube Carcinoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 29 |
| Primary completion | 2027-04-08 |
| Primary endpoint | Number of Patients Achieving Complete or Partial Response |
| Registry ID | NCT03113487 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:56:17.355Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03113487
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.